English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduImplantable penile prostheses (IPPs) are an established treatment option for erectile dysfunction (ED), and are covered by insurance in about 80% of cases, reports a paper in the September issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Tag: Insurance Coverage
UTHealth Houston expert available to discuss VA’s coverage of Alzheimer’s drug
Paul E. Schulz, MD, neurologist with UTHealth Houston and Memorial Hermann, is available over the next few days to comment on recent news that the Veterans Health Administration will provide coverage for Leqembi, which recently received accelerated approval from the…
Study: Non-discriminatory state-level insurance can improve access to gender-affirming care
Implementation of a state-level insurance policy that prohibits discrimination based on gender identity or gender expression can increase access to gender-affirming surgical care, according to a new study by The Ohio State University Wexner Medical Center and College of Medicine.
Ochsner Health Reveals New Findings: Digital Health Pilot Dramatically Improves Outcomes for Medicaid Patients Battling Chronic Diseases, Among First to Do So
The statistically and clinically significant results of the pilot program– one of the first in the country – showed that enrollment in Ochsner Digital Medicine brought nearly half of all out-of-control Hypertension patients under control at only 90 days.
Underinsured Transgender Americans More Likely to Turn to Riskier Sources for Gender-Affirming Hormones
People who are transgender and lack access to insurance coverage for gender-affirming hormone therapy are more likely to turn to sources other than a licensed health care provider, a new Michigan Medicine-led study finds.
JNCCN Study Explores if Insurance is Keeping Pace with Trends in Targeted Cancer Therapy
New research from the University of California, San Francisco (USCF) and City of Hope in the July 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network examines coverage trends for circulating tumor DNA testing, also known as gene sequencing of ctDNA or “liquid biopsies.” The researchers found coverage rate rose from 0% to 38% in three years. The policies also increased in scope from 2017-2019, going from one cancer type to 12.
AED and STRIPED Team Up with Deloitte to Conduct a Comprehensive US Economic Impact Study
AED and STRIPED Team Up with Deloitte to Conduct a Comprehensive US Economic Impact Study